Skip to content

KNSA

Kiniksa Pharmaceuticals, Ltd.

NASDAQ · BMHealthcareBiotechnology
$62.58-2.14%

Price as of Jul 20, 2026

KNSA analysis

Kiniksa Pharmaceuticals, Ltd. stock analysis

Published Drillr research and company-specific analysis. Existing articles keep their current URLs and citation behavior.

Analysis for KNSA is not published yet

Browse the public research library while company-specific analysis is being prepared. Explore research